Health Catalyst stockholders elect directors, ratify auditor, approve exec compensation at annual meeting

Health Catalyst, Inc.

Elected Anita V. Pramoda and S. Dawn Smith as Class I directors for three-year terms expiring 2026.
Ratified Ernst & Young as independent auditor for FY2023 with 47,292,765 votes for, 108,336 against.
Advisory vote on named executive officer compensation approved with 40,672,307 for, 1,663,691 against.
Total shares outstanding: 56,259,662; 46,806,678 present at meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Health Catalyst, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-14 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-14

Exact text from the filing

Proposal 2 – Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company’s consolidated financial statements for the fiscal year ending December 31, 2023. The results of such vote were as follows: Votes For Votes Against Abstentions 47,292,765 108,336 5,674

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Health Catalyst, Inc. shareholders approved Election of two Class I directors to serve three-year terms expiring at the 2026 annual meeting at the 2023-06-14 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-14

Exact text from the filing

Proposal 1 – Election of Directors The Company’s stockholders elected each of the two persons named below to serve as a Class I director of the Company to serve a three-year term expiring at the 2026 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation. The results of such vote were as follows: Director Name Votes For Votes Withheld Broker Non-Votes Anita V. Pramoda 30,037,200 12,313,217 5,056,358 S. Dawn Smith 30,403,681 11,946,736 5,056,358

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Health Catalyst, Inc. shareholders approved Advisory, non-binding vote to approve the compensation of the Company’s named executive officers at the 2023-06-14 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-14

Exact text from the filing

Proposal 3 – Advisory, Non-Binding Vote to Approve the Compensation of the Company’s Named Executive Officers The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company’s named executive officers. The results of such vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 40,672,307 1,663,691 14,419 5,056,358

View on SEC.gov

550 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Health Catalyst, Inc. filing history →

Source: SEC EDGAR

accession 0001636422-23-000086

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.